CWL heads into the end of April with an unusual tension at its core: the stock is up 19% over the past month, yet the cost of borrowing it has climbed to its highest level in over a year — suggesting that some participants are willing to pay a meaningful premium to express a bearish view against what is otherwise a quietly improving small-cap name.
The borrow market tells the most interesting story here. Cost to borrow has climbed to 16.1% annualised, up roughly 16% on the week and nearly 17% over the past month — its steepest level since at least mid-2025, when it was running below 10%. That is an elevated rate for a stock of this size and liquidity. The lending pool is effectively maxed out: the most recent availability data shows every share in the pool already lent, meaning there is no meaningful buffer for new shorts to establish positions without bidding up the rate further. Short interest itself is tiny in absolute terms — just 0.02% of the free float — so the tightness in borrow is not the result of a crowded short; it reflects structural scarcity in a very thinly traded name.
The short score, at 32.8, has been essentially flat for the past two weeks and sits in the 51st percentile of the universe — unremarkable. Days to cover ranks in the 86th percentile, a product of how lightly traded the stock is rather than any meaningful short pressure. What is worth noting is that estimated short shares jumped from under 1,000 at end-March to over 7,000 by mid-April, a spike driven from a very low base. The absolute number remains negligible, but the direction of travel — combined with a borrow rate heading higher as the stock prices up — points to someone paying a real cost to maintain a position.
The catalyst context helps frame the setup. Caldwell reported Q2 results on April 9, with revenue of CAD $27.3M against CAD $23.2M a year prior — a clean improvement for the executive search and leadership advisory firm. The stock reacted well: up 7.6% the day after and 20% over the following five trading sessions. That post-earnings run drove most of the one-month gain. Ewing Morris & Co., the largest institutional holder with a 12.9% stake, has not changed its position since January, providing a stable anchor in a stock where the free float is already thin.
Insider data is stale beyond the 90-day threshold, so the recent trades on record — CEO Carl Beck and Executive Chairman John Wallace both sold small tranches at around CAD $0.94–$0.95 in January — are now too dated to read as fresh signals. The pattern at that time was awards followed by immediate sales, consistent with routine compensation settlements rather than conviction selling.
The dividend history last shows a payment in January 2020. No subsequent dividend data is available, so income is not a live theme here.
What to watch: the post-earnings rally has now run to CAD $0.93. The key question is whether the borrow rate continues to climb as the stock holds near its one-year highs, and whether the thin lending pool either forces short covering or attracts new supply — either outcome would likely move the cost-to-borrow needle meaningfully from current levels.
See the live data behind this article on ORTEX.
Open CWL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
